{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:27:44Z","timestamp":1793284064454,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Research Projects in Higher Education Institutions in Anhui Province","award":["2023AH050584"],"award-info":[{"award-number":["2023AH050584"]}]},{"name":"Natural Science Foundation of Anhui Medical University","award":["2022xkj214"],"award-info":[{"award-number":["2022xkj214"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-04930-y","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:16:50Z","timestamp":1745799410000},"page":"5292-5304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic performance of apparent diffusion coefficient values in differentiating benign from malignant lesions in prostate PI-RADS v2.1 category 1 \u201cnodules in nodule\u201d"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9541-1483","authenticated-orcid":false,"given":"Minghua","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"4930_CR1","doi-asserted-by":"publisher","unstructured":"Gelikman DG, Azar WS, Yilmaz EC, Lin Y, Shumaker LA, Fang AM, et al. A Prostate Imaging-Reporting and Data System version 2.1-based predictive model for clinically significant prostate cancer diagnosis. BJU Int 2024;9. doi: https:\/\/doi.org\/10.1111\/bju.16616.","DOI":"10.1111\/bju.16616"},{"issue":"1","key":"4930_CR2","doi-asserted-by":"publisher","first-page":"e2329964","DOI":"10.2214\/AJR.23.29964","volume":"222","author":"EC Yilmaz","year":"2024","unstructured":"Yilmaz EC, Lin Y, Belue MJ, Harmon SA, Phelps TE, Merriman KM, et al. PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy. AJR Am J Roentgenol 2024;222(1):e2329964. doi: https:\/\/doi.org\/10.2214\/AJR.23.29964.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"4930_CR3","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/jmri.29268","volume":"60","author":"MJ Kim","year":"2024","unstructured":"Kim MJ, Park JJ, Kang KA, Park SY, Kim CK. Utility of Prostate Health Index Density for Biopsy Strategy in Biopsy-Na\u00efve Patients With PI-RADS v2.1 Category 3 Lesions. J Magn Reson Imaging 2024;60(4):1628\u20131636. doi: https:\/\/doi.org\/10.1002\/jmri.29268.","journal-title":"J Magn Reson Imaging"},{"key":"4930_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 2019;76(3):340\u2013351. doi: https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033."},{"issue":"2","key":"4930_CR5","doi-asserted-by":"publisher","first-page":"e233337","DOI":"10.1148\/radiol.233337","volume":"312","author":"B Oerther","year":"2024","unstructured":"Oerther B, Nedelcu A, Engel H, Schmucker C, Schwarzer G, Brugger T, et al. Update on PI-RADS Version 2.1 Diagnostic Performance Benchmarks for Prostate MRI: Systematic Review and Meta-Analysis. Radiology 2024;312(2):e233337. doi: https:\/\/doi.org\/10.1148\/radiol.233337.","journal-title":"Radiology"},{"issue":"10","key":"4930_CR6","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.1007\/s00330-021-07855-4","volume":"31","author":"CS Lim","year":"2021","unstructured":"Lim CS, Abreu-Gomez J, Flood TA, Carrion I, Dallaire FB, Schieda N. Prevalence of prostate cancer in PI-RADS version 2.1 T2-weighted transition zone \u2018nodule in nodule\u2019 and \u2018homogeneous mildly hypointense area between nodules\u2019 criteria: MRI-radical prostatectomy histopathological evaluation. Eur Radiol 2021;31(10):7792\u20137801. doi: https:\/\/doi.org\/10.1007\/s00330-021-07855-4.","journal-title":"Eur Radiol"},{"key":"4930_CR7","doi-asserted-by":"publisher","unstructured":"Sun M, Xu L, Zhang X, Cao L, Chen W, Liu K, et al. PI-RADS v2.1 evaluation of prostate \u201cnodule in nodule\u201d variants: clinical, imaging, and pathological features. Insights Imaging 2024; 18;15(1):79. doi: https:\/\/doi.org\/10.1186\/s13244-024-01651-6.","DOI":"10.1186\/s13244-024-01651-6"},{"issue":"1","key":"4930_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1148\/radiol.2015150244","volume":"278","author":"M Iima","year":"2016","unstructured":"Iima M, Le Bihan D. Clinical Intravoxel Incoherent Motion and Diffusion MR Imaging: Past, Present, and Future. Radiology 2016; 278(1):13\u201332. doi: https:\/\/doi.org\/10.1148\/radiol.2015150244.","journal-title":"Radiology"},{"issue":"1","key":"4930_CR9","doi-asserted-by":"publisher","first-page":"e233055","DOI":"10.1148\/radiol.233055","volume":"313","author":"MA Boss","year":"2024","unstructured":"Boss MA, Malyarenko D, Partridge S, Obuchowski N, Shukla-Dave A, Winfield JM, et al. The QIBA Profile for Diffusion-Weighted MRI: Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker. Radiology 2024;313(1):e233055. doi: https:\/\/doi.org\/10.1148\/radiol.233055.","journal-title":"Radiology"},{"issue":"9","key":"4930_CR10","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.1007\/s00330-023-09788-6","volume":"33","author":"A Surov","year":"2023","unstructured":"Surov A, Eger KI, Potratz J, Gottschling S, Wienke A, Jechorek D. Apparent diffusion coefficient correlates with different histopathological features in several intrahepatic tumors. Eur Radiol 2023;33(9):5955\u20135964. doi: https:\/\/doi.org\/10.1007\/s00330-023-09788-6.","journal-title":"Eur Radiol"},{"issue":"10","key":"4930_CR11","doi-asserted-by":"publisher","first-page":"e1189-e1195","DOI":"10.1016\/j.crad.2024.04.016","volume":"79","author":"N Kikkawa","year":"2024","unstructured":"Kikkawa N, Sugawara H, Yoshida H, Kobayashi-Kato M, Tanase Y, Uno M, et al. Characteristics of the magnetic resonance imaging findings of cervical gastric-type adenocarcinoma. Clin Radiol 2024;79(10):e1189-e1195. doi: https:\/\/doi.org\/10.1016\/j.crad.2024.04.016.","journal-title":"Clin Radiol"},{"issue":"1","key":"4930_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s00330-024-10890-6","volume":"35","author":"G Agrotis","year":"2025","unstructured":"Agrotis G, Pooch E, Abdelatty M, Benson S, Vassiou A, Vlychou M, et al. Diagnostic performance of ADC and ADCratio in MRI-based prostate cancer assessment: A systematic review and meta-analysis. Eur Radiol 2025;35(1):404\u2013416.","journal-title":"Eur Radiol"},{"issue":"9","key":"4930_CR13","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.21037\/tau-24-235","volume":"30","author":"Y Imai","year":"2024","unstructured":"Imai Y, Urabe F, Sadakane I, Oguchi T, Iwatani K, Murakami M, et al. Optimizing prostate cancer detection in transition zone: an analysis of apparent diffusion coefficient values in prostate magnetic resonance imaging evaluation with Prostate Imaging Reporting and Data System (PI-RADS) assessment. Transl Androl Urol 2024; 30;13(9):2027\u20132035. doi: https:\/\/doi.org\/10.21037\/tau-24-235.","journal-title":"Transl Androl Urol"},{"issue":"1","key":"4930_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1148\/radiol.212692","volume":"306","author":"AA Tavakoli","year":"2023","unstructured":"Tavakoli AA, Hielscher T, Badura P, G\u00f6rtz M, Kuder TA, Gnirs R, et al. Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer. Radiology 2023;306(1):186\u2013199. doi: https:\/\/doi.org\/10.1148\/radiol.212692.","journal-title":"Radiology"},{"issue":"2","key":"4930_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41391-023-00760-5","volume":"27","author":"S Deivasigamani","year":"2024","unstructured":"Deivasigamani S, Adams ES, Kotamarti S, Mottaghi M, Taha T, Aminsharifi A, et al. Comparison of procedural anxiety and pain associated with conventional transrectal ultrasound prostate biopsy to magnetic resonance imaging-ultrasound fusion-guided biopsy: a prospective cohort trial. Prostate Cancer Prostatic Dis 2024;27(2):294\u2013299. doi: https:\/\/doi.org\/10.1038\/s41391-023-00760-5.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4930_CR16","doi-asserted-by":"publisher","unstructured":"Kornienko K, Reuter M, Maxeiner A, G\u00fcnzel K, Kittner B, Reimann M, et al. Follow-up of men with a PI-RADS 4\/5 lesion after negative MRI\/Ultrasound fusion biopsy. Sci Rep 2022; 10;12(1):13603. doi: https:\/\/doi.org\/10.1038\/s41598-022-17260-6.","DOI":"10.1038\/s41598-022-17260-6"},{"issue":"11","key":"4930_CR17","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.acra.2020.07.027","volume":"28","author":"S Ghafoor","year":"2021","unstructured":"Ghafoor S, Becker AS, Woo S, Causa Andrieu PI, Stocker D, Gangai N, et al. Comparison of PI-RADS Versions 2.0 and 2.1 for MRI-based Calculation of the Prostate Volume. Acad Radiol 2021;28(11):1548\u20131556. doi: https:\/\/doi.org\/10.1016\/j.acra.2020.07.027.","journal-title":"Acad Radiol"},{"issue":"9","key":"4930_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/cancers13092047","volume":"13","author":"M Maggi","year":"2021","unstructured":"Maggi M, Del Giudice F, Falagario UG, Cocci A, Russo GI, Di Mauro M, et al. SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study. Cancers (Basel) 2021 23;13(9):2047. doi: https:\/\/doi.org\/10.3390\/cancers13092047.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4930_CR19","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41391-021-00367-8","volume":"24","author":"RJ Hendriks","year":"2021","unstructured":"Hendriks RJ, van der Leest MMG, Isra\u00ebl B, Hannink G, YantiSetiasti A, Cornel EB, et al. Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-na\u00efve men. Prostate Cancer Prostatic Dis 2021;24(4):1110\u20131119. doi: https:\/\/doi.org\/10.1038\/s41391-021-00367-8.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4930_CR20","doi-asserted-by":"publisher","first-page":"111496","DOI":"10.1016\/j.forsciint.2022.111496","volume":"343","author":"T Yu","year":"2023","unstructured":"Yu T, Chen Z, Yin H, Yi N, Zhao M. Statistical issues on evaluating agreement between THC and 11-OH-THC analysis in hair samples by Cohen\u2019s kappa. Forensic Sci Int 2023;343:111496. doi: https:\/\/doi.org\/10.1016\/j.forsciint.2022.111496.","journal-title":"Forensic Sci Int"},{"issue":"5","key":"4930_CR21","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1037\/met0000516","volume":"29","author":"D Ten Hove","year":"2024","unstructured":"Ten Hove D, Jorgensen TD, van der Ark LA. Updated guidelines on selecting an intraclass correlation coefficient for interrater reliability, with applications to incomplete observational designs. Psychol Methods 2024;29(5):967\u2013979. doi: https:\/\/doi.org\/10.1037\/met0000516.","journal-title":"Psychol Methods"},{"issue":"1","key":"4930_CR22","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1080\/07853890.2021.1990394","volume":"53","author":"L Yang","year":"2021","unstructured":"Yang L, Sun R, Wei N, Chen H. Systematic review and meta-analysis of risk scores in prediction for the clinical outcomes in patients with acute variceal bleeding. Ann Med 2021;53(1):1806\u20131815. doi: https:\/\/doi.org\/10.1080\/07853890.2021.1990394.","journal-title":"Ann Med"},{"issue":"3","key":"4930_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s11604-024-01675-4","volume":"43","author":"N Yamaya","year":"2025","unstructured":"Yamaya N, Kimura K, Ichikawa R, Kawanishi M, Kawasaki Y, Higuchi S, et al. Prospective evaluation of PI-RADSv2.1 using multiparametric and biparametric MRI for detecting clinically significant prostate cancer based on MRI\/US fusion-guided biopsy. Jpn J Radiol 2025;43(3):472\u2013482. doi: https:\/\/doi.org\/10.1007\/s11604-024-01675-4.","journal-title":"Jpn J Radiol"},{"issue":"4","key":"4930_CR24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/pros.24658","volume":"84","author":"H Huang","year":"2024","unstructured":"Huang H, Liu Z, Ma Y, Shao Y, Yang Z, Duan D, et al. Based on PI-RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4\u201320 ng\/mL. Prostate 2024;84(4):376\u2013388. doi: https:\/\/doi.org\/10.1002\/pros.24658.","journal-title":"Prostate"},{"key":"4930_CR25","doi-asserted-by":"publisher","first-page":"925186","DOI":"10.3389\/fonc.2022.925186","volume":"12","author":"H Sun","year":"2022","unstructured":"Sun H, Du F, Liu Y, Li Q, Liu X, Wang T. DCE-MRI and DWI can differentiate benign from malignant prostate tumors when serum PSA is \u2265\u200910 ng\/mL. Front. Oncol 2022; 12:925186. doi: https:\/\/doi.org\/10.3389\/fonc.2022.925186.","journal-title":"Front. Oncol"},{"issue":"3","key":"4930_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2214\/AJR.20.23932","volume":"216","author":"CS Lim","year":"2021","unstructured":"Lim CS, Abreu-Gomez J, Carrion I, Schieda N. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy. AJR Am J Roentgenol 2021;216(3):683\u2013690. doi: https:\/\/doi.org\/10.2214\/AJR.20.23932.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"4930_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2214\/AJR.20.24370","volume":"217","author":"DN Costa","year":"2021","unstructured":"Costa DN, Jia L, Subramanian N, Xi Y, Rofsky NM, Recchimuzzi DZ, et al. Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules with Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI. AJR Am J Roentgenol 2021;217(2):395\u2013403. doi: https:\/\/doi.org\/10.2214\/AJR.20.24370.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"4930_CR28","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1038\/s41598-024-57337-y","volume":"19","author":"J Wen","year":"2024","unstructured":"Wen J, Liu W, Shen X, Hu W. PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4\u201310 ng\/mL. Sci Rep 2024 19;14(1):6570. doi: https:\/\/doi.org\/10.1038\/s41598-024-57337-y.","journal-title":"Sci Rep"},{"issue":"2","key":"4930_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/aja202182","volume":"24","author":"XD Gao","year":"2022","unstructured":"Gao XD, Miao Q, Zhang JL, Zhai JZ, Gui XM, Cai YH, et al. Clinical application of free\/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0\u201325.0 ng ml-1 in Western China. Asian J Androl 2022;24(2):195\u2013200. doi: https:\/\/doi.org\/10.4103\/aja202182.","journal-title":"Asian J Androl"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-04930-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-04930-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-04930-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:03:24Z","timestamp":1761847404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-04930-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4930"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-04930-y","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.eururo.2019.02.033","asserted-by":"subject"}]},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}